APA (7th ed.) Citation

Liu, C., Zhao, X., Zhu, S., Yu, H., Xing, W., & Li, H. Predictors of recurrence after conversion therapy in unresectable hepatocellular carcinoma treated with HAIC, bevacizumab, and sintilimab. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Liu, Chang-Fu, Xiao-Hui Zhao, Shi-Bo Zhu, Hai-Peng Yu, Wen-Ge Xing, and Hui-Kai Li. Predictors of Recurrence After Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated with HAIC, Bevacizumab, and Sintilimab. Frontiers Media S.A.

MLA (9th ed.) Citation

Liu, Chang-Fu, et al. Predictors of Recurrence After Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated with HAIC, Bevacizumab, and Sintilimab. Frontiers Media S.A.